SEC 13F Intelligence

Privium Fund Management B.V. / ITCIEUR

Privium Fund Management B.V.’s Intra-Cellular Therapies Inc Position

Does Privium Fund Management B.V. own Intra-Cellular Therapies Inc (ITCIEUR)? Not currently — the last reported position was 97.2K shares worth $8M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q4 2024
Shares
97.2K
% of Portfolio
+1.84%
Quarters Held
7
position exited

Position History ITCIEUR

Reported value by quarter
Q2 ’23: $5MQ2 ’23Q3 ’23: $5MQ3 ’23Q4 ’23: $7MQ4 ’23Q1 ’24: $8MQ1 ’24Q2 ’24: $8MQ2 ’24Q3 ’24: $9MQ3 ’24Q4 ’24: $8MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202497.2K$8M+1.84%
Q3 2024118.0K$9M+2.15%
Q2 2024118.0K$8M+2.06%
Q1 2024108.9K$8M+2.01%
Q4 202394.0K$7M+1.85%
Q3 202393.7K$5M+1.45%
Q2 202383.7K$5M+1.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Privium Fund Management B.V.’s full portfolio or all institutional holders of ITCIEUR.